Detailed information for compound 436340

Basic information

Technical information
  • TDR Targets ID: 436340
  • Name: 5-thiophen-2-yl-1,3-thiazol-2-amine
  • MW: 182.266 | Formula: C7H6N2S2
  • H donors: 1 H acceptors: 1 LogP: 1.98 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1ncc(s1)c1cccs1
  • InChi: 1S/C7H6N2S2/c8-7-9-4-6(11-7)5-2-1-3-10-5/h1-4H,(H2,8,9)
  • InChiKey: ZRAMCXSKRBJHHU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-(2-thienyl)thiazol-2-amine
  • 5-(2-thienyl)-2-thiazolamine
  • [5-(2-thienyl)thiazol-2-yl]amine
  • Oprea1_406381

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0004 0.0633 0.0633
Loa Loa (eye worm) intermediate filament tail domain-containing protein 0.0004 0.0656 0.0656
Schistosoma mansoni hypothetical protein 0.0008 0.178 0.1203
Loa Loa (eye worm) intermediate filament protein 0.0004 0.0656 0.0656
Echinococcus multilocularis lamin dm0 0.0004 0.0656 0.0635
Echinococcus granulosus intermediate filament protein 0.0004 0.0656 0.0635
Loa Loa (eye worm) hypothetical protein 0.0036 1 1
Loa Loa (eye worm) hypothetical protein 0.0002 0.0022 0.0022
Brugia malayi intermediate filament protein 0.0004 0.0656 1
Schistosoma mansoni calcium-activated potassium channel 0.0023 0.6251 0.5988
Echinococcus multilocularis small conductance calcium activated potassium 0.0036 1 1
Onchocerca volvulus 0.0004 0.0656 0.5
Onchocerca volvulus 0.0004 0.0656 0.5
Brugia malayi Intermediate filament tail domain containing protein 0.0004 0.0656 1
Loa Loa (eye worm) hypothetical protein 0.0012 0.3025 0.3025
Schistosoma mansoni calcium-activated potassium channel 0.0036 1 1
Loa Loa (eye worm) hypothetical protein 0.0004 0.0656 0.0656
Loa Loa (eye worm) cytoplasmic intermediate filament protein 0.0002 0.0087 0.0087
Loa Loa (eye worm) hypothetical protein 0.0012 0.2831 0.2831
Loa Loa (eye worm) hypothetical protein 0.0011 0.2657 0.2657
Schistosoma mansoni hypothetical protein 0.0036 1 1
Echinococcus granulosus lamin 0.0004 0.0656 0.0635
Echinococcus multilocularis lamin 0.0004 0.0656 0.0635
Echinococcus multilocularis musashi 0.0004 0.0656 0.0635
Echinococcus granulosus lamin dm0 0.0004 0.0656 0.0635

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 55 uM Inhibition of Hsp90-dependent luciferase renaturation in rabbit reticulocyte after 30 mins by luciferase refolding assay ChEMBL. 17223347
IC50 (functional) > 100 uM Antiproliferative activity against MCF7 cells after 72 hrs ChEMBL. 17223347
IC50 (functional) > 100 uM Antiproliferative activity against SkBr3 cells after 72 hrs ChEMBL. 17223347
IC50 (functional) > 100 uM Induction of Hsp90-dependent Her2 protein degradation in Skbr3 cells after 24 hrs by ELISA ChEMBL. 17223347
IC50 (functional) > 100 uM Antiproliferative activity against MCF7 cells after 72 hrs ChEMBL. 17223347
IC50 (functional) > 100 uM Antiproliferative activity against SkBr3 cells after 72 hrs ChEMBL. 17223347
IC50 (functional) > 100 uM Induction of Hsp90-dependent Her2 protein degradation in Skbr3 cells after 24 hrs by ELISA ChEMBL. 17223347

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.